The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review

被引：34

作者：

Liem, Sophie I. E. ^{[1
]}

Vlieland, Theodora P. M. Vliet ^{[2
]}

Schoones, Jan W. ^{[3
]}

de Vries-Bouwstra, Jeska K. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Rheumatol, C1-R,POB 9600, NL-2300 RC Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Dept Orthopaed Rehabil Med & Phys Therapy, Leiden, Netherlands

[3] Leiden Univ, Med Ctr, Walaeus Lib, Leiden, Netherlands

来源：

RHEUMATOLOGY ADVANCES IN PRACTICE | 2019年 / 3卷 / 02期

关键词：

systemic sclerosis; scleroderma; exercise therapy; exercise; review; UPDATED METHOD GUIDELINES; REHABILITATION PROGRAM; USUAL CARE; EFFICACY; FEASIBILITY; QUALITY; TRIALS;

D O I：

10.1093/rap/rkz044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Given the shortcomings of previous literature reviews evaluating the effect and safety of exercise therapy in SSc, we aimed to carry out a systematic review of the literature specifically on this topic. A structured search strategy was performed in Medline (via PubMed) and other electronic databases from 1990 to 3 September 2019. Randomized controlled trials, observational designs, conference abstracts and trial registrations were included if they concerned SSc patients >= 18 years of age, exercise therapy and reported outcomes related to physical functioning. Nine articles were included. Four randomized controlled trials compared (a) hand exercises, (b) orofacial exercises, (c) aerobic exercises or (d) aerobic exercises plus resistance training with no exercise, demonstrating effects on hand function (a), maximum mouth opening (b), peak oxygen uptake (c+d) and quality of life. All five observational studies concerning hand, orofacial, aerobic and/or strengthening exercises reported improvements of hand function, mouth opening, aerobic capacity and/or muscle strength. In conclusion, the evidence on the effect and safety of exercise therapy in SSc is scanty.

引用

页数：13

共 50 条

[11] CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts [J].